261 related articles for article (PubMed ID: 6337707)
1. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
2. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
[TBL] [Abstract][Full Text] [Related]
3. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
[TBL] [Abstract][Full Text] [Related]
4. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
[TBL] [Abstract][Full Text] [Related]
5. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
[TBL] [Abstract][Full Text] [Related]
6. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
[TBL] [Abstract][Full Text] [Related]
7. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
[TBL] [Abstract][Full Text] [Related]
8. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
Duerst RE; Rose D; Frantz CN
Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
10. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
Stong RC; Youle RJ; Vallera DA
Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
[TBL] [Abstract][Full Text] [Related]
11. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
Ritz J; Pesando JM; Notis-McConarty J; Clavell LA; Sallan SE; Schlossman SF
Cancer Res; 1981 Nov; 41(11 Pt 2):4771-5. PubMed ID: 6945904
[TBL] [Abstract][Full Text] [Related]
12. Mouse L1210V leukemia as a model to analyse efficiency of leukemic cell elimination by immunotoxin, antibody and complement, and cytostatic agents.
Paprocka M; Wiedlocha A; Radzikowski C
In Vivo; 1990; 4(3):209-13. PubMed ID: 2133264
[TBL] [Abstract][Full Text] [Related]
13. [Lysis of leukemia cells with a monoclonal antibody-cocktail (e.g. VIP-pool) and human complement].
Reiners B; Thränhardt H; Häfer R; Zintl F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):84-96. PubMed ID: 2439421
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
15. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
[TBL] [Abstract][Full Text] [Related]
16. Heparin inhibition of antibody-dependent complement-mediated lysis.
Wesolowski J; Ault K; Houghton R; Parkman R
Exp Hematol; 1984 Oct; 12(9):700-5. PubMed ID: 6237929
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia.
Bai Y; Piao XH; Luo QL; Mao BZ
Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation in acute lymphoblastic leukemia--preclinical immunologic studies.
Janossy G; Campana D; Burnett A; Coustan-Smith E; Timms A; Bekassy AN; Hann I; Alcorn MJ; Totterman T; Simonsson B
Leukemia; 1988 Aug; 2(8):485-95. PubMed ID: 3045431
[TBL] [Abstract][Full Text] [Related]
19. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
Uckun FM; Stong RC; Youle RJ; Vallera DA
J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
[TBL] [Abstract][Full Text] [Related]
20. Elimination of malignant clonogenic cells from human bone marrow using multiple myeloid cell-specific monoclonal antibodies and complement.
Hu ZB; Yu ZF; Qiao CN; Ma WL
Chin Med J (Engl); 1991 Aug; 104(8):664-8. PubMed ID: 1914634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]